OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+25.06%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.29%
AUM
$288M
AUM Growth
+$288M
(+19%)
Cap. Flow
+$14.9M
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
61.77%
Holding
53
New
11
Increased
10
Reduced
18
Closed
13
Top Buys
| 1 |
Biohaven
BHVN
|
$7.5M |
| 2 |
Harrow
HROW
|
$6.36M |
| 3 |
KalVista Pharmaceuticals
KALV
|
$6.24M |
| 4 |
Phathom Pharmaceuticals
PHAT
|
$4.68M |
| 5 |
Karyopharm Therapeutics
KPTI
|
$4.28M |
Top Sells
| 1 |
CUTR
Cutera, Inc.
CUTR
|
$6.74M |
| 2 |
ProQR Therapeutics
PRQR
|
$6.12M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$5.25M |
| 4 |
Merus
MRUS
|
$5.07M |
| 5 |
Keros Therapeutics
KROS
|
$4M |
Sector Composition
| 1 | Healthcare | 98.86% |